| Gary Ross Sirken, DO | |
|
825 Town Center Drive, Suite 152, Langhorne, PA 19047-3030 | |
| (215) 741-3510 | |
| (215) 741-3519 |
| Full Name | Gary Ross Sirken |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 825 Town Center Drive, Langhorne, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164469334 | NPI | - | NPPES |
| 0019054860003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | OS010180L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Center Of Bucks County | Bristol, PA | Dialysis facility |
| Woodhaven Dialysis Center | Bensalem, PA | Dialysis facility |
| Bensalem Dialysis Center | Bensalem, PA | Dialysis facility |
| Langhorne Dialysis Center | Langhorne, PA | Dialysis facility |
| Davita - Grant One Dialysis Center | Philadelphia, PA | Dialysis facility |
| Jefferson Heath | Philadelphia, PA | Hospital |
| St Mary Medical Center | Langhorne, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Renal Associates Llc | 6901881366 | 29 |
News Archive
The simple training exercise of catching a weighted medicine ball can improve balance and may help prevent falls in the elderly, according to research at the University of Illinois at Chicago.
IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling "a deadly fungus, aflatoxin," which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the "literally billions of people in the developing world" who are chronically exposed to the fungus.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.
› Verified 9 days ago
| Entity Name | Clinical Renal Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689620254 PECOS PAC ID: 6901881366 Enrollment ID: O20040621000636 |
News Archive
The simple training exercise of catching a weighted medicine ball can improve balance and may help prevent falls in the elderly, according to research at the University of Illinois at Chicago.
IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling "a deadly fungus, aflatoxin," which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the "literally billions of people in the developing world" who are chronically exposed to the fungus.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.
› Verified 9 days ago
| Entity Name | Kidney And Hypertension Associates P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457308314 PECOS PAC ID: 4486632247 Enrollment ID: O20040709000246 |
News Archive
The simple training exercise of catching a weighted medicine ball can improve balance and may help prevent falls in the elderly, according to research at the University of Illinois at Chicago.
IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling "a deadly fungus, aflatoxin," which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the "literally billions of people in the developing world" who are chronically exposed to the fungus.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Ross Sirken, DO Po Box 538, Levittown, PA 19058-0538 Ph: (215) 741-3510 | Gary Ross Sirken, DO 825 Town Center Drive, Suite 152, Langhorne, PA 19047-3030 Ph: (215) 741-3510 |
News Archive
The simple training exercise of catching a weighted medicine ball can improve balance and may help prevent falls in the elderly, according to research at the University of Illinois at Chicago.
IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling "a deadly fungus, aflatoxin," which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the "literally billions of people in the developing world" who are chronically exposed to the fungus.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.
› Verified 9 days ago
Vincent Michael Figueredo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Dr. Gregory P Zollner, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 240 Middletown Blvd, Ste 200, Langhorne, PA 19047 Phone: 215-757-5772 Fax: 215-757-5494 | |
Dr. John A Volpe, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 234, Langhorne, PA 19047 Phone: 215-750-2911 Fax: 215-750-2917 | |
Ellen Miller, DO Nephrology Medicare: Medicare Enrolled Practice Location: 825 Town Center Dr, Suite 152, Langhorne, PA 19047 Phone: 215-741-3510 Fax: 215-741-3519 | |
Jonathan Gold, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd, Suite 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Ronald H Fields, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd, Suite 320, Langhorne, PA 19047 Phone: 215-750-7818 Fax: 215-752-0436 | |
Fozia Farooqui, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1203 Langhorne Newtown Rd Ste 226, Langhorne, PA 19047 Phone: 215-710-4460 Fax: 215-710-4465 |